Journal of Clinical and Cellular Immunology
Open Access
ISSN: 2155-9899
ISSN: 2155-9899
Shomir Ghosh
Tempero Pharmaceuticals, a GSK company, Cambridge, MA, USA
Shomir Ghosh is currently working at Tempero Pharmaceuticals, a GSK company, Cambridge, MA, USA. One of his major publication is Small Molecule Inhibitors Targeting the Th17 Cell Transcription Factor RORγt for the Treatment of Autoimmune Diseases. He has published many articles in reputed journals.
Autoimmune Diseases, Immunology